Cancer chemotherapy administered via hemodialysis fistulas

Cancer chemotherapy administered via hemodialysis fistulas

End-stage renal failure (ESRF) patients can develop cancer before or after kidney disease occurs. Cancer chemotherapy often needs to be administered via the sort of central venous catheter that is normally avoided in ESRF care. Three cases are presented in which ESRF patients received chemotherapy f...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The journal of vascular access 2005-10, Vol.6 (4), p.196-199
Hauptverfasser: Harney, J, Ahmed, S, Faccini, K, Raymond, J, Lind, P, Nye, S, McGill, R L
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 199
container_issue 4
container_start_page 196
container_title The journal of vascular access
container_volume 6
creator Harney, J
Ahmed, S
Faccini, K
Raymond, J
Lind, P
Nye, S
McGill, R L
description End-stage renal failure (ESRF) patients can develop cancer before or after kidney disease occurs. Cancer chemotherapy often needs to be administered via the sort of central venous catheter that is normally avoided in ESRF care. Three cases are presented in which ESRF patients received chemotherapy for cancer via existing hemodialysis fistulas, and the consequences of central venous access in a fourth patient are discussed.
doi_str_mv 10.1177/112972980500600408
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_70150063</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>70150063</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2608-6727b506a8515e27b6509aecc2a55ebc2b9c9cc624f907e4262f5201ed51b5643</originalsourceid><addsrcrecordid>eNplkE1Lw0AQhhdRbK3-AQ-Sk7fozCS7m_UmxS8oeNFz2GwmdCVp6m4j9N-b0IIHT_PCPO97eIS4RrhD1PoekYwmU4AEUAA5FCdijpryVEFGp2MegXQiZuIixi8AMhLzczFDJSVpoLl4WNqN45C4NXf9bs3BbveJrTu_8XHHgevkx9tketbetvvoY9KMn6G18VKcNbaNfHW8C_H5_PSxfE1X7y9vy8dV6khBkSpNupKgbCFR8piVBGPZObJScuWoMs44pyhvDGjOSVEjCZBriZVUebYQt4fdbei_B467svPRcdvaDfdDLDXgJCAbQTqALvQxBm7KbfCdDfsSoZyMlf-NjaWb4_pQdVz_VY6Ksl9AkmUu</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>70150063</pqid></control><display><type>article</type><title>Cancer chemotherapy administered via hemodialysis fistulas</title><source>SAGE Complete A-Z List</source><creator>Harney, J ; Ahmed, S ; Faccini, K ; Raymond, J ; Lind, P ; Nye, S ; McGill, R L</creator><creatorcontrib>Harney, J ; Ahmed, S ; Faccini, K ; Raymond, J ; Lind, P ; Nye, S ; McGill, R L</creatorcontrib><description>End-stage renal failure (ESRF) patients can develop cancer before or after kidney disease occurs. Cancer chemotherapy often needs to be administered via the sort of central venous catheter that is normally avoided in ESRF care. Three cases are presented in which ESRF patients received chemotherapy for cancer via existing hemodialysis fistulas, and the consequences of central venous access in a fourth patient are discussed.</description><identifier>ISSN: 1129-7298</identifier><identifier>EISSN: 1724-6032</identifier><identifier>DOI: 10.1177/112972980500600408</identifier><identifier>PMID: 16552702</identifier><language>eng</language><publisher>United States</publisher><ispartof>The journal of vascular access, 2005-10, Vol.6 (4), p.196-199</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c2608-6727b506a8515e27b6509aecc2a55ebc2b9c9cc624f907e4262f5201ed51b5643</citedby><cites>FETCH-LOGICAL-c2608-6727b506a8515e27b6509aecc2a55ebc2b9c9cc624f907e4262f5201ed51b5643</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,778,782,27907,27908</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16552702$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Harney, J</creatorcontrib><creatorcontrib>Ahmed, S</creatorcontrib><creatorcontrib>Faccini, K</creatorcontrib><creatorcontrib>Raymond, J</creatorcontrib><creatorcontrib>Lind, P</creatorcontrib><creatorcontrib>Nye, S</creatorcontrib><creatorcontrib>McGill, R L</creatorcontrib><title>Cancer chemotherapy administered via hemodialysis fistulas</title><title>The journal of vascular access</title><addtitle>J Vasc Access</addtitle><description>End-stage renal failure (ESRF) patients can develop cancer before or after kidney disease occurs. Cancer chemotherapy often needs to be administered via the sort of central venous catheter that is normally avoided in ESRF care. Three cases are presented in which ESRF patients received chemotherapy for cancer via existing hemodialysis fistulas, and the consequences of central venous access in a fourth patient are discussed.</description><issn>1129-7298</issn><issn>1724-6032</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2005</creationdate><recordtype>article</recordtype><recordid>eNplkE1Lw0AQhhdRbK3-AQ-Sk7fozCS7m_UmxS8oeNFz2GwmdCVp6m4j9N-b0IIHT_PCPO97eIS4RrhD1PoekYwmU4AEUAA5FCdijpryVEFGp2MegXQiZuIixi8AMhLzczFDJSVpoLl4WNqN45C4NXf9bs3BbveJrTu_8XHHgevkx9tketbetvvoY9KMn6G18VKcNbaNfHW8C_H5_PSxfE1X7y9vy8dV6khBkSpNupKgbCFR8piVBGPZObJScuWoMs44pyhvDGjOSVEjCZBriZVUebYQt4fdbei_B467svPRcdvaDfdDLDXgJCAbQTqALvQxBm7KbfCdDfsSoZyMlf-NjaWb4_pQdVz_VY6Ksl9AkmUu</recordid><startdate>200510</startdate><enddate>200510</enddate><creator>Harney, J</creator><creator>Ahmed, S</creator><creator>Faccini, K</creator><creator>Raymond, J</creator><creator>Lind, P</creator><creator>Nye, S</creator><creator>McGill, R L</creator><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>200510</creationdate><title>Cancer chemotherapy administered via hemodialysis fistulas</title><author>Harney, J ; Ahmed, S ; Faccini, K ; Raymond, J ; Lind, P ; Nye, S ; McGill, R L</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2608-6727b506a8515e27b6509aecc2a55ebc2b9c9cc624f907e4262f5201ed51b5643</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2005</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Harney, J</creatorcontrib><creatorcontrib>Ahmed, S</creatorcontrib><creatorcontrib>Faccini, K</creatorcontrib><creatorcontrib>Raymond, J</creatorcontrib><creatorcontrib>Lind, P</creatorcontrib><creatorcontrib>Nye, S</creatorcontrib><creatorcontrib>McGill, R L</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>The journal of vascular access</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Harney, J</au><au>Ahmed, S</au><au>Faccini, K</au><au>Raymond, J</au><au>Lind, P</au><au>Nye, S</au><au>McGill, R L</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Cancer chemotherapy administered via hemodialysis fistulas</atitle><jtitle>The journal of vascular access</jtitle><addtitle>J Vasc Access</addtitle><date>2005-10</date><risdate>2005</risdate><volume>6</volume><issue>4</issue><spage>196</spage><epage>199</epage><pages>196-199</pages><issn>1129-7298</issn><eissn>1724-6032</eissn><abstract>End-stage renal failure (ESRF) patients can develop cancer before or after kidney disease occurs. Cancer chemotherapy often needs to be administered via the sort of central venous catheter that is normally avoided in ESRF care. Three cases are presented in which ESRF patients received chemotherapy for cancer via existing hemodialysis fistulas, and the consequences of central venous access in a fourth patient are discussed.</abstract><cop>United States</cop><pmid>16552702</pmid><doi>10.1177/112972980500600408</doi><tpages>4</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1129-7298
ispartof The journal of vascular access, 2005-10, Vol.6 (4), p.196-199
issn 1129-7298
1724-6032
language eng
recordid cdi_proquest_miscellaneous_70150063
source SAGE Complete A-Z List
title Cancer chemotherapy administered via hemodialysis fistulas
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-16T19%3A26%3A48IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Cancer%20chemotherapy%20administered%20via%20hemodialysis%20fistulas&rft.jtitle=The%20journal%20of%20vascular%20access&rft.au=Harney,%20J&rft.date=2005-10&rft.volume=6&rft.issue=4&rft.spage=196&rft.epage=199&rft.pages=196-199&rft.issn=1129-7298&rft.eissn=1724-6032&rft_id=info:doi/10.1177/112972980500600408&rft_dat=%3Cproquest_cross%3E70150063%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=70150063&rft_id=info:pmid/16552702&rfr_iscdi=true